<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="b80edf6d-72dc-41d4-a1ea-8ba5be8bd7cc"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Consultation — Frédéric Chopin — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="18380320120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="602c2174-5da2-4a57-8367-c1a685138084"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="3b7655ed-b522-485f-ade3-a54d9884e453" extension="HR-NI020-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-20-8845"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Frédéric</given><family>Chopin</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="18100301"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="18380320120000-0500"/>
    <assignedAuthor><id root="7bddd875-17d0-42ba-92b1-71713851b0ee"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Ewa</given><family>Kowalczyk-Grant</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="18380320120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="7bddd875-17d0-42ba-92b1-71713851b0ee"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Ewa</given><family>Kowalczyk-Grant</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="dbb8ff02-6e72-4849-8f8e-9c85f3ef1ccc"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="18380320"/><high value="18380320"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="7bddd875-17d0-42ba-92b1-71713851b0ee"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Ewa</given><family>Kowalczyk-Grant</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="5c9e8945-948a-405b-820b-3cbee15aa9b6"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the four-month rifapentine-moxifloxacin regimen by video-observed therapy</originalText></code>
      <effectiveTime><low value="18380320"/><high value="18380320"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="7bddd875-17d0-42ba-92b1-71713851b0ee"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Ewa</given><family>Kowalczyk-Grant</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Suspected cavitary pulmonary tuberculosis in a 28-year-old pianist and piano teacher with three months of cough, blood-streaked sputum, night sweats, and weight loss, and a lifelong history of chest illness. Please confirm the diagnosis when the sputum results return, advise on the regimen, monitoring, and his return to teaching, and tell us whether cystic fibrosis or alpha-1 antitrypsin deficiency needs to be excluded. [S]</paragraph><paragraph>Urgency: Urgent, on the day the sputum results return (expected within three days). [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Do the results confirm pulmonary tuberculosis, and does anything else need to be considered?</item><item>Is he eligible for the four-month rifapentine-moxifloxacin regimen, and would you choose it over the six-month regimen?</item><item>What monitoring does he need, given his low weight and albumin?</item><item>When can he leave isolation and teach his students again?</item><item>Should cystic fibrosis or alpha-1 antitrypsin deficiency be tested for, given his lifelong chest illness?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Chopin, a 28-year-old pianist who teaches in his apartment, is seen at the request of Dr. Lindqvist three days after presenting with three months of cough, two weeks of blood-streaked sputum, night sweats, evening fevers, and weight loss. He has coughed up blood once more since. He has had recurrent coughs and fevers with colds since his teens, but he has never had a diagnosis of a chronic lung disease, nasal polyps, sinus disease, greasy stools, or liver disease. He has never been treated for tuberculosis and knows of no contact with drug-resistant disease. He takes no medicines and has no history of heart rhythm problems or fainting. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Fryderyk Franciszek Chopin was born in the village of Żelazowa Wola, in Mazovia, on March 1, 1810, according to his own statements and his family&apos;s; his baptismal certificate, written several weeks after the birth, gives February 22. [D]</item><item>His father, Mikołaj (Nicolas) Chopin, was a Frenchman from Lorraine who settled permanently in Poland and brought up his children as Poles; the family moved to Warsaw a few months after Fryderyk&apos;s birth. [D]</item><item>In 1827 the youngest of the Chopin children, his sister Emilia, died of tuberculosis. [D]</item><item>A review of the documentary sources reports recurrent episodes of cough, fever, headaches, and swollen lymph nodes beginning in his teens. [D]</item><item>He left Warsaw on November 2, 1830, never to return, reached Paris in September 1831, and in 1834 chose the status of a political refugee rather than apply to the Russian embassy for a passport. [D]</item><item>In Paris his most important source of income was giving lessons; he became a popular teacher, and although ranked among the greatest pianists of his time, he disliked public performances, appeared rarely, and preferred an intimate group of listeners. [D]</item><item>In 1836 a proposal of marriage was accepted on condition that he take better care of his health; the engagement ended a year later, the family of his fiancée being disturbed by the bad state of his health, as he had been seriously ill in the winter. [D]</item><item>He met the writer George Sand in Paris in 1836; their relationship, which began soon after, lasted nearly ten years. [D]</item></list><paragraph>12 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="78a9fd2d-c0eb-4857-b6b9-9132b17cd613"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="d808b674-30a3-4594-84d3-0f92e9346e08"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Rifapentine 150 mg tablets, eight tablets (1200 mg) daily with food</td><td>1200 mg once daily with a meal by video-observed therapy with the health department, seven days a week, for 17 weeks (119 doses)</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Moxifloxacin 400 mg tablet, one tablet daily</td><td>400 mg once daily with the other drugs by video-observed therapy with the health department, seven days a week, for 17 weeks; no mineral supplements within 4 hours before or 8 hours after</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Isoniazid 300 mg tablet, one tablet daily</td><td>300 mg once daily by video-observed therapy with the health department, seven days a week, for 17 weeks</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily</td><td>1000 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase (weight band 40 to under 55 kg)</td><td>Oral route</td><td>1838-03-20 to 1838-05-14</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily</td><td>50 mg once daily with isoniazid</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="1748953d-e4e2-4efb-bf30-36ad3cedfe24"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1200" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="242671" codeSystem="2.16.840.1.113883.6.88" displayName="rifapentine 150 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4fa33ec2-6bef-447c-afbd-6b1b33d7e15d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="d5a591a9-acc9-441c-a2be-855ea6227b4b"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="400" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="311787" codeSystem="2.16.840.1.113883.6.88" displayName="moxifloxacin 400 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="adfc8759-8cae-4e9a-8c22-086b346bccd9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="dbda3077-514d-4a45-b836-3a9096acdfb7"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="300" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197832" codeSystem="2.16.840.1.113883.6.88" displayName="isoniazid 300 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="bf19d6d8-4202-4038-aec3-d79599caf92d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="fb6ba3b2-daaa-4b55-94e0-31fa689722a7"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380514"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198181" codeSystem="2.16.840.1.113883.6.88" displayName="pyrazinamide 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="c9d7dd8e-5e3d-459b-bb76-d68001f23f4b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ed86835c-155c-48a8-b94e-22413c68343a"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="639566" codeSystem="2.16.840.1.113883.6.88" displayName="vitamin B6 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7b665376-b799-4123-956f-f5a59e6359d8"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture</td><td>resolved</td><td>confirmed</td>
    <td>R04.2</td><td>S — Synthetic presenting problem linked to his documented chronic cough and hemoptysis; superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance</td><td>active</td><td>confirmed</td>
    <td>A15.0</td><td>S — Synthetic modern coding of his documented tuberculosis, chosen over the disputed genetic and cardiac alternatives; the cavity and all bacteriology are synthetic.</td>
  </tr>
  <tr ID="problem-3">
    <td>Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL</td><td>active</td><td>confirmed</td>
    <td>E44.0</td><td>S — Synthetic nutrition diagnosis anchored to his documented frailty and exhaustion.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7273f904-2f9f-43fc-b51b-1de29ca555bc"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9c332de1-f7fc-49ea-ab9e-76c294ab655b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="R04.2" codeSystem="2.16.840.1.113883.6.90" displayName="Hemoptysis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="5826947b-f17a-4a6e-b4df-c3d40173e109"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="79d9a1d2-506b-4e0b-91be-b36ea00b901d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a69a02e0-4185-4209-9b86-9d12a533fd2c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9f5a06f5-c136-4193-a6aa-27f81636c523"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/></effectiveTime>
          <value xsi:type="CD" code="E44.0" codeSystem="2.16.840.1.113883.6.90" displayName="Moderate protein-calorie malnutrition"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1838-03-20; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Thin and tired; temperature 37.6 °C, pulse 98; seen in an airborne infection isolation room</td></tr><tr><td>Ears, nose, and throat</td><td>No nasal polyps</td></tr><tr><td>Respiratory</td><td>Coarse crackles and bronchial breathing over the right upper zone; fine crackles at the left apex</td></tr><tr><td>Extremities</td><td>No clubbing</td></tr><tr><td>Musculoskeletal</td><td>Tendons non-tender</td></tr><tr><td>Neurological</td><td>Normal sensation in the fingers and feet</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Pulmonary tuberculosis, cavitary and smear-positive (A15.0). Confirmed by a positive amplification test with three positive smears, in keeping with the cavity and the symptoms. No rifampin resistance. A positive interferon-gamma release assay supports the diagnosis but would not have excluded it if negative. Nontuberculous mycobacteria do not give a positive amplification test for the tuberculosis complex. Cultures, molecular tests for isoniazid and fluoroquinolone resistance, and phenotypic susceptibility are pending. [S]</item><item>Choice of regimen. He is eligible for the four-month regimen: age over 12, weight 48.4 kg, pulmonary disease only, HIV negative, no prolonged QT history or QT-prolonging medicines, normal potassium and magnesium, normal liver tests and creatinine, no earlier treatment, and specimens sent for susceptibility before the first dose. A cavity does not exclude it. Compared with the six-month regimen it shortens treatment by two months, which matters to him as a teacher and performer, at the cost of more tablets taken with food and the moxifloxacin precautions. He chose it after hearing both options. [S]</item><item>Monitoring. An electrocardiogram is not routinely needed, because he has no QT risk factors. His low weight and albumin justify one early liver check even without symptoms. Moxifloxacin can cause tendon injury and, with isoniazid, nerve damage, which would matter greatly to a pianist; both should be asked about at every visit and every observed dose. [S]</item><item>Isolation and return to teaching. He remains infectious until he has had at least two weeks of treatment, his symptoms are improving, and three sputum smears collected at least eight hours apart are negative. After that, with the health department&apos;s agreement, he can teach in person and needs no mask. [S]</item><item>Cystic fibrosis and alpha-1 antitrypsin deficiency. Neither is likely: the CT shows no bronchiectasis or emphysema, he has no sinus or pancreatic symptoms, and tuberculosis fully explains his illness. Because his lifelong chest illness raises the question and he wants it answered, a sweat chloride test and a serum alpha-1 antitrypsin level are reasonable and simple; a sweat chloride below 30 mmol/L makes cystic fibrosis unlikely. [S]</item><item>Moderate protein-calorie malnutrition (E44.0). Undernutrition raises the risk of poor outcomes and drug toxicity; pyridoxine is needed with isoniazid. [S]</item></list><paragraph>Data reviewed: Dr. Lindqvist&apos;s note; the chest X-ray and CT; three sputum smears (2+, 2+, 1+); the nucleic acid amplification test (Mycobacterium tuberculosis complex detected, rifampin resistance not detected); the interferon-gamma release assay (positive); HIV-1/2 antigen and antibody (negative); hepatitis B surface antigen and core antibody (negative) with surface antibody positive; hepatitis C antibody (negative); and the baseline blood count, liver and kidney tests, potassium, calcium, and magnesium. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Start today: rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg (weight band 40 to under 55 kg) once daily with food for eight weeks (56 doses), then rifapentine, moxifloxacin, and isoniazid for nine weeks (63 doses), with pyridoxine 50 mg, all by video-observed therapy seven days a week; the regimen is complete at 119 doses, with the intensive phase within 70 days and the whole regimen within five months. [S]</item><item>No mineral supplements, antacids, or zinc products within four hours before or eight hours after the dose; review any new medicine for interactions with rifapentine or for QT effects with moxifloxacin. [S]</item><item>Liver tests in two to three weeks and at once for hepatitis symptoms; stop the doses and call for ALT above three times the upper limit with symptoms or five times without. [S]</item><item>Ask about tendon pain and numbness or tingling at every visit; stop moxifloxacin for tendon pain. [S]</item><item>Three sputum smears in the third week for release from isolation; monthly sputum culture until two are negative, including the two-month culture; send any positive two-month culture for repeat susceptibility testing. [S]</item><item>Phenotypic susceptibility to rifampin, isoniazid, pyrazinamide, and moxifloxacin on the first isolate; change the regimen if any resistance is found. [S]</item><item>Sweat chloride test and serum alpha-1 antitrypsin level at the next visit, once he is out of isolation. [S]</item><item>Dietitian support with supplement drinks taken in the afternoon or evening, away from the dose. [S]</item><item>No electrocardiogram unless symptoms or a new QT-prolonging medicine arise. [S]</item><item>I will review the results by message at two months and at the end of treatment; no further infectious diseases visit unless the cultures stay positive, resistance is found, or a drug must be stopped. [S]</item><item>Discussed with Dr. Lindqvist, who saw him the same morning, and with the health department tuberculosis nurse who will observe his doses by video. The regimen, its precautions, and the release criteria were explained to Mr. Chopin, who chose the four-month regimen and asked for written advice for his students; the health department will contact them directly. [S]</item><item>Follow-up: Results review by message at two months and at the end of treatment; sooner for liver injury, tendon pain, positive cultures at two months, or resistance. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
